4//SEC Filing
Crystal Adam 4
Accession 0000950170-23-058314
CIK 0001819133other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 4:49 PM ET
Size
4.8 KB
Accession
0000950170-23-058314
Insider Transaction Report
Form 4
Crystal Adam
See Remarks
Transactions
- Sale
Common Stock
2023-11-01$8.39/sh−7,507$62,994→ 81,250 total
Footnotes (1)
- [F1]Includes 7,507 shares that were acquired on October 31, 2023 pursuant to the Tango Therapeutics, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001825445
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 4:49 PM ET
- Size
- 4.8 KB